These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 8754418

  • 1. [Hepatitis C following administration of intravenous immunoglobulins].
    Cabrera Chaves T, Simón Marco MA, Gomollón García F, Botella Esteban MT, Uribarrena Echebarría R.
    Gastroenterol Hepatol; 1996; 19(6):305-8. PubMed ID: 8754418
    [Abstract] [Full Text] [Related]

  • 2. Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1994 Jul 22; 43(28):505-9. PubMed ID: 8022396
    [Abstract] [Full Text] [Related]

  • 3. Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency.
    Razvi S, Schneider L, Jonas MM, Cunningham-Rundles C.
    Clin Immunol; 2001 Dec 22; 101(3):284-8. PubMed ID: 11726220
    [Abstract] [Full Text] [Related]

  • 4. Follow-up of four HIV-infected individuals after administration of hepatitis C virus and GBV-C/hepatitis G virus contaminated intravenous immunoglobulin: evidence for HCV but not for GBV-C/HGV transmission.
    Berger A, Doerr HW, Scharrer I, Weber B.
    J Med Virol; 1997 Sep 22; 53(1):25-30. PubMed ID: 9298728
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis C and immune globulin.
    López-Jiménez J, Odriozola J, Pérez-Oteyza J, García-Laraña J.
    N Engl J Med; 1995 May 04; 332(18):1235-6. PubMed ID: 7700324
    [No Abstract] [Full Text] [Related]

  • 6. [Study on the epidemiology and distribution of human immunodeficiency virus-1 and hepatitis C virus infection among intravenous drug users and illegal blood donors in China].
    Yin N, Mei S, Li L, Wei FL, Zhang LQ, Cao YZ.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov 04; 24(11):962-5. PubMed ID: 14687492
    [Abstract] [Full Text] [Related]

  • 7. [Epidemiological information obtained from anti-hepatitis C virus screening in blood donors and candidates for autologous transfusion from 1992 to 1996 in the Alpes-Maritimes region].
    Ouzan D, Pesle B, Baldini E, Rimbourg H, Darphin F, Cohen N, Brichetti A, Follana R.
    Gastroenterol Clin Biol; 2000 Mar 04; 24(3):337-41. PubMed ID: 10804343
    [Abstract] [Full Text] [Related]

  • 8. 111 cases of hepatitis C linked to Gammagard. Patient screening recommended.
    Am J Hosp Pharm; 1994 Oct 01; 51(19):2326. PubMed ID: 7847397
    [No Abstract] [Full Text] [Related]

  • 9. [Laboratory markers in hepatitis C virus infection in patients with antibody formation disorders treated with immunoglobulin preparations].
    Litzman J, Pejcochová J, Lokaj J.
    Vnitr Lek; 1996 May 01; 42(5):324-6. PubMed ID: 8768290
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis C transmission associated with intravenous immunoglobulins.
    Nübling CM, Willkommen H, Löwer J.
    Lancet; 1995 May 06; 345(8958):1174. PubMed ID: 7536875
    [No Abstract] [Full Text] [Related]

  • 11. The safety of immune globulins.
    Tepper M, Gully P.
    Can Commun Dis Rep; 1996 Jul 15; 22(14):117-9. PubMed ID: 8754937
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of the French national plan to promote screening and early management of viral hepatitis C, between 1997 and 2003: a comparative cross-sectional study in Poitou-Charentes region.
    Defossez G, Verneau A, Ingrand I, Silvain C, Ingrand P, Beauchant M, Poitou-Charentes Hepatitis C Network.
    Eur J Gastroenterol Hepatol; 2008 May 15; 20(5):367-72. PubMed ID: 18403936
    [Abstract] [Full Text] [Related]

  • 13. [The problem of hepatitis C virus infection in blood donors. Clinico-epidemiological, virological and histological evaluation].
    Sookoian S, Castaño G, Castiglioni T, Pilar S, Viudez P, González J, Frider B.
    Medicina (B Aires); 1997 May 15; 57(6):699-707. PubMed ID: 9674191
    [Abstract] [Full Text] [Related]

  • 14. From the Centers for Disease Control and Prevention. Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994.
    JAMA; 1994 Aug 10; 272(6):424-5. PubMed ID: 8040966
    [No Abstract] [Full Text] [Related]

  • 15. [Epidemiology of hepatitis C virus infection in 1,304 HCV positive patients: variations according to the origin of transmission and year of diagnosis].
    Guyader D, Lefeuvre C, Jacquelinet S, Prat M, Baudouard Y, Turlin B, André P, Mendler MH, Sapey T, Boucher E, Moirand R, Messner M, Colimon R, Brissot P, Deugnier Y.
    Gastroenterol Clin Biol; 1998 Apr 10; 22(4):375-80. PubMed ID: 9762266
    [Abstract] [Full Text] [Related]

  • 16. Follow-up studies of hepatitis C association with an intravenous immunoglobulin.
    Yu MW.
    Dev Biol Stand; 1996 Apr 10; 88():215-6. PubMed ID: 9119139
    [No Abstract] [Full Text] [Related]

  • 17. [Screening of patients at risk for hepatitis C virus infection in general medicine].
    Altman C, Lesiour A, Dunbavand A, Meyer L, de la Selle P, Buffet C.
    Gastroenterol Clin Biol; 1999 Mar 10; 23(3):359-62. PubMed ID: 10384340
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis.
    Lovy MR, Starkebaum G, Uberoi S.
    J Rheumatol; 1996 Jun 10; 23(6):979-83. PubMed ID: 8782126
    [Abstract] [Full Text] [Related]

  • 19. Experimental experience with virus validation studies.
    Willkommen H.
    Dev Biol Stand; 1996 Jun 10; 88():317-8. PubMed ID: 9119155
    [No Abstract] [Full Text] [Related]

  • 20. Hepatitis C and immune globulin.
    Prince AM, Horowitz B.
    N Engl J Med; 1995 May 04; 332(18):1236; author reply 1236-7. PubMed ID: 7700325
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.